Hanne Hella
Norwegian University of Science and Technology(NO)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, TGF-β signaling in diseases, Bone health and treatments, Heterotopic Ossification and Related Conditions, Ubiquitin and proteasome pathways
Most-Cited Works
- → Addiction to c-MYC in multiple myeloma(2012)177 cited
- → Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B(2015)174 cited
- → Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells(2016)67 cited
- → BMPR2 inhibits activin and BMP signaling via wild-type ALK2(2018)58 cited
- → Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors(2020)47 cited
- → Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC(2011)45 cited
- → Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate(2013)42 cited
- → High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis(2009)37 cited
- → CpG-Oligodeoxynucleotide Inhibits Smad-Dependent Bone Morphogenetic Protein Signaling: Effects on Myeloma Cell Apoptosis and In Vitro Osteoblastogenesis(2010)21 cited
- → Nonlabeled secondary antibodies augment/maintain the binding of primary, specific antibodies to cell membrane antigens(2001)13 cited